Amgen Senior VP-Research and Development Joseph Miletich: An Interview With “The Pink Sheet” DAILY (Part 1 of 3)

Exec discusses Amgen’s drug development strategy and pipeline and his concerns regarding follow-on biologics, personalized medicine and other issues.

More from Archive

More from Pink Sheet